Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate Industry News March 3, 2022 …
Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis CBRNE February 27, 2022 …
Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
First Lethal Hamster Model for SARS-CoV-2 Developed by USAMRIID Scientists Medical Countermeasures February 4, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta Medical Countermeasures January 21, 2022 …
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy Medical Countermeasures December 16, 2021 …
Biodefense and Countering Disease with Neutralizing Antibodies Medical Countermeasures December 15, 2021 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
Does AstraZeneca’s COVID Vaccine Give Longer-Lasting Protection Than mRNA Shots? Medical Countermeasures December 4, 2021 …
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development Medical Countermeasures November 18, 2021 …
JPEO-CBRND Seeks Prototype Proposals for Vaccine Acceleration Program Contracts + Grants November 15, 2021 …
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray Industry News November 9, 2021 …
Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines Medical Countermeasures November 8, 2021 …
